Aceprometazine
From Wikipedia, the free encyclopedia
This article does not cite any sources. (December 2010) (Learn how and when to remove this template message) |
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal and fecal |
Identifiers | |
|
|
CAS Number | 13461-01-3 |
PubChem (CID) | 26035 |
DrugBank | DB01615 |
ChemSpider | 24249 |
UNII | 984N9YTM4Y |
ChEBI | CHEBI:53770 |
ChEMBL | CHEMBL2104054 |
ECHA InfoCard | 100.033.315 |
Chemical and physical data | |
Formula | C19H22N2OS |
Molar mass | 326.456 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Aceprometazine (INN) is a phenothiazine derivative prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine.
References[edit]
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |